Matlib M A, Zhou Z, Knight S, Ahmed S, Choi K M, Krause-Bauer J, Phillips R, Altschuld R, Katsube Y, Sperelakis N, Bers D M
Department of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio 45267-0575, USA.
J Biol Chem. 1998 Apr 24;273(17):10223-31. doi: 10.1074/jbc.273.17.10223.
Ruthenium red is a well known inhibitor of Ca2+ uptake into mitochondria in vitro. However, its utility as an inhibitor of Ca2+ uptake into mitochondria in vivo or in situ in intact cells is limited because of its inhibitory effects on sarcoplasmic reticulum Ca2+ release channel and other cellular processes. We have synthesized a ruthenium derivative and found it to be an oxygen-bridged dinuclear ruthenium amine complex. It has the same chemical structure as Ru360 reported previously (Emerson, J., Clarke, M. J., Ying, W-L., and Sanadi, D. R. (1993) J. Am. Chem. Soc. 115, 11799-11805). Ru360 has been shown to be a potent inhibitor of Ca2+-stimulated respiration of liver mitochondria in vitro. However, the specificity of Ru360 on Ca2+ uptake into mitochondria in vitro or in intact cells has not been determined. The present study reports in detail the potency, the effectiveness, and the mechanism of inhibition of mitochondrial Ca2+ uptake by Ru360 and its specificity in vitro in isolated mitochondria and in situ in isolated cardiac myocytes. Ru360 was more potent (IC50 = 0.184 nM) than ruthenium red (IC50 = 6.85 nM) in inhibiting Ca2+ uptake into mitochondria. 103Ru360 was found to bind to isolated mitochondria with high affinity (Kd = 0.34 nM, Bmax = 80 fmol/mg of mitochondrial protein). The IC50 of 103Ru360 for the inhibition of Ca2+ uptake into mitochondria was also 0.2 nM, indicating that saturation of a specific binding site is responsible for the inhibition of Ca2+ uptake. Ru360, as high as 10 microM, produced no effect on sarcoplasmic reticulum Ca2+ uptake or release, sarcolemmal Na+/Ca2+ exchange, actomyosin ATPase activity, L-type Ca2+ channel current, cytosolic Ca2+ transients, or cell shortening. 103Ru360 was taken up by isolated myocytes in a time-dependent biphasic manner. Ru360 (10 microM) applied outside intact voltage-clamped ventricular myocytes prevented Ca2+ uptake into mitochondria in situ where the cells were progressively loaded with Ca2+ via sarcolemmal Na+/Ca2+ exchange by depolarization to +110 mV. We conclude that Ru360 specifically blocks Ca2+ uptake into mitochondria and can be used in intact cells.
钌红是一种在体外对钙离子摄入线粒体具有显著抑制作用的物质。然而,由于其对肌浆网钙离子释放通道和其他细胞过程有抑制作用,其在体内或完整细胞原位作为线粒体钙离子摄入抑制剂的效用有限。我们合成了一种钌衍生物,发现它是一种氧桥联双核钌胺配合物。它与先前报道的Ru360具有相同的化学结构(艾默生,J.,克拉克,M. J.,应,W - L.,和萨纳迪,D. R.(1993年)《美国化学会志》115,11799 - 11805)。Ru360已被证明在体外是肝线粒体钙离子刺激呼吸的有效抑制剂。然而,Ru360在体外或完整细胞中对线粒体钙离子摄入的特异性尚未确定。本研究详细报道了Ru360对线粒体钙离子摄入的抑制效力、有效性和机制,以及其在体外分离线粒体和原位分离心肌细胞中的特异性。Ru360在抑制钙离子摄入线粒体方面比钌红(IC50 = 6.85 nM)更有效(IC50 = 0.184 nM)。发现103Ru360以高亲和力(Kd = 0.34 nM,Bmax = 80 fmol/mg线粒体蛋白)结合到分离的线粒体上。103Ru360抑制线粒体钙离子摄入的IC50也为0.2 nM,表明特定结合位点的饱和是钙离子摄入抑制的原因。高达10 microM的Ru360对肌浆网钙离子摄入或释放、肌膜钠/钙交换、肌动球蛋白ATP酶活性、L型钙离子通道电流、胞质钙离子瞬变或细胞缩短均无影响。103Ru360以时间依赖性双相方式被分离的心肌细胞摄取。在完整的电压钳制心室肌细胞外部施加Ru360(10 microM)可防止原位线粒体钙离子摄入,在此过程中,细胞通过去极化至 +110 mV经肌膜钠/钙交换逐渐加载钙离子。我们得出结论,Ru360特异性阻断线粒体钙离子摄入,可用于完整细胞。